Overview

• Attorneys general from all 50 states, Washington D.C. and four territories have signed on to resolve thousands of lawsuits over Purdue Pharma’s marketing of OxyContin.
• The settlement calls for $6.5 billion in payments from the Sackler family and $900 million from Purdue Pharma, to be disbursed over 15 years with $2.4 billion due in the first three years.
• Funds will support addiction prevention, treatment and recovery initiatives nationwide, with state and local governments determining specific allocations.
• Under the agreement, the Sackler family must relinquish control of Purdue Pharma and is barred from selling opioids while Purdue Pharma cannot market or lobby for opioid drugs.
• Final approval depends on a scheduled hearing before U.S. Bankruptcy Judge Sean Lane in the coming days.